FDA OKs Zituvimet XR for adults with T2DM

Zituvimet XR (sitagliptin and metformin hydrochloride) extended release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with T2DM. The most common adverse reactions (incidence ≥5%), occurring more often in patients who simultaneously started on sitagliptin and metformin vs. placebo, were diarrhea, upper respiratory tract infection, and headache.